Martijn C de Wilde1, Cassia R Overk2, John W Sijben1, Eliezer Masliah3. 1. Nutricia Advanced Medical Nutrition, Nutricia Research, Utrecht, The Netherlands. 2. Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA. 3. Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA; Department of Pathology, University of California, San Diego, La Jolla, CA, USA. Electronic address: emasliah@ucsd.edu.
Abstract
INTRODUCTION: Loss of synapses best correlates to cognitive deficits in Alzheimer's disease (AD) in which oligomeric neurotoxic species of amyloid-β appears to contribute synaptic pathology. Although a number of clinical pathologic studies have been performed with limited sample size, there are no systematic studies encompassing large samples. Therefore, we performed a meta-analysis study. METHODS: We identified 417 publications reporting postmortem synapse and synaptic marker loss from AD patients. Two meta-analyses were performed using a single database of subselected publications and calculating the standard mean differences. RESULTS: Meta-analysis confirmed synaptic loss in selected brain regions is an early event in AD pathogenesis. The second meta-analysis of 57 synaptic markers revealed that presynaptic makers were affected more than postsynaptic markers. DISCUSSION: The present meta-analysis study showed a consistent synaptic loss across brain regions and that molecular machinery including endosomal pathways, vesicular assembly mechanisms, glutamate receptors, and axonal transport are often affected.
INTRODUCTION: Loss of synapses best correlates to cognitive deficits in Alzheimer's disease (AD) in which oligomeric neurotoxic species of amyloid-β appears to contribute synaptic pathology. Although a number of clinical pathologic studies have been performed with limited sample size, there are no systematic studies encompassing large samples. Therefore, we performed a meta-analysis study. METHODS: We identified 417 publications reporting postmortem synapse and synaptic marker loss from ADpatients. Two meta-analyses were performed using a single database of subselected publications and calculating the standard mean differences. RESULTS: Meta-analysis confirmed synaptic loss in selected brain regions is an early event in AD pathogenesis. The second meta-analysis of 57 synaptic markers revealed that presynaptic makers were affected more than postsynaptic markers. DISCUSSION: The present meta-analysis study showed a consistent synaptic loss across brain regions and that molecular machinery including endosomal pathways, vesicular assembly mechanisms, glutamate receptors, and axonal transport are often affected.
Authors: H Lassmann; R Weiler; P Fischer; C Bancher; K Jellinger; E Floor; W Danielczyk; F Seitelberger; H Winkler Journal: Neuroscience Date: 1992 Impact factor: 3.590
Authors: R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman Journal: Ann Neurol Date: 1991-10 Impact factor: 10.422
Authors: Sophie Sokolow; Sanh H Luu; Karabi Nandy; Carol A Miller; Harry V Vinters; Wayne W Poon; Karen H Gylys Journal: Neurobiol Dis Date: 2011-09-03 Impact factor: 5.996
Authors: Stephen W Scheff; Douglas A Price; Frederick A Schmitt; Kelly N Roberts; Milos D Ikonomovic; Elliott J Mufson Journal: J Alzheimers Dis Date: 2013 Impact factor: 4.472
Authors: Nicolai Franzmeier; Jinyi Ren; Alexander Damm; Gemma Monté-Rubio; Mercè Boada; Agustín Ruiz; Alfredo Ramirez; Frank Jessen; Emrah Düzel; Octavio Rodríguez Gómez; Tammie Benzinger; Alison Goate; Celeste M Karch; Anne M Fagan; Eric McDade; Katharina Buerger; Johannes Levin; Marco Duering; Martin Dichgans; Marc Suárez-Calvet; Christian Haass; Brian A Gordon; Yen Ying Lim; Colin L Masters; Daniel Janowitz; Cihan Catak; Steffen Wolfsgruber; Michael Wagner; Esther Milz; Sonia Moreno-Grau; Stefan Teipel; Michel J Grothe; Ingo Kilimann; Martin Rossor; Nick Fox; Christoph Laske; Jasmeer Chhatwal; Peter Falkai; Robert Perneczky; Jae-Hong Lee; Annika Spottke; Henning Boecker; Frederic Brosseron; Klaus Fliessbach; Michael T Heneka; Peter Nestor; Oliver Peters; Manuel Fuentes; Felix Menne; Josef Priller; Eike J Spruth; Christiana Franke; Anja Schneider; Christine Westerteicher; Oliver Speck; Jens Wiltfang; Claudia Bartels; Miguel Ángel Araque Caballero; Coraline Metzger; Daniel Bittner; Stephen Salloway; Adrian Danek; Jason Hassenstab; Igor Yakushev; Peter R Schofield; John C Morris; Randall J Bateman; Michael Ewers Journal: Mol Psychiatry Date: 2019-03-21 Impact factor: 15.992
Authors: Ming-Kai Chen; Adam P Mecca; Mika Naganawa; Jean-Dominique Gallezot; Takuya Toyonaga; Jayanta Mondal; Sjoerd J Finnema; Shu-Fei Lin; Ryan S O'Dell; Julia W McDonald; Hannah R Michalak; Brent Vander Wyk; Nabeel B Nabulsi; Yiyun Huang; Amy Ft Arnsten; Christopher H van Dyck; Richard E Carson Journal: J Cereb Blood Flow Metab Date: 2021-03-24 Impact factor: 6.200
Authors: Ari W Schaler; Avery M Runyan; Catherine L Clelland; Eric J Sydney; Stephanie L Fowler; Helen Y Figueroa; Seiji Shioda; Ismael Santa-Maria; Karen E Duff; Natura Myeku Journal: Sci Transl Med Date: 2021-05-26 Impact factor: 17.956